Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Bionik Laboratories Corp. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 4.92M | $2.95M | $0.60 | Jun 13, 2023 | Shares held through GD Holdings and Lombard International Assurance SA |
Bionik Laboratories Corp. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 61.3K | $36.8K | $0.60 | Jun 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BNKL | Bionik Laboratories Corp. | Jun 13, 2023 | 1 | $1.86M | 4 | Jun 21, 2023 | Director, 10%+ Owner |
BNKL | Bionik Laboratories Corp. | Jun 9, 2023 | 1 | $108K | 4 | Jun 21, 2023 | Director, 10%+ Owner |
BNKL | Bionik Laboratories Corp. | Mar 31, 2022 | 1 | $740K | 4 | Jun 21, 2022 | Director, 10%+ Owner |
BNKL | Bionik Laboratories Corp. | Jul 15, 2021 | 4 | $0 | 4 | Dec 13, 2021 | Director, 10%+ Owner |
BNKL | Bionik Laboratories Corp. | Mar 29, 2021 | 1 | $0 | 4 | Dec 13, 2021 | Director, 10%+ Owner |
BNKL | Bionik Laboratories Corp. | Mar 26, 2021 | 1 | $0 | 4 | Dec 13, 2021 | Director, 10%+ Owner |